Abpro Holdings, Inc. (ABPO)
0.5775
+0.02
(+3.12%)
USD |
OTCM |
Nov 06, 16:00
Abpro Holdings Enterprise Value : -0.1111M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | -0.1111M |
| November 05, 2026 | -0.2141M |
| November 04, 2026 | -0.568M |
| November 03, 2026 | -0.6634M |
| November 02, 2026 | -0.9029M |
| October 30, 2026 | -0.943M |
| October 29, 2026 | -0.9968M |
| October 28, 2026 | -0.9747M |
| October 27, 2026 | -1.211M |
| October 26, 2026 | -1.209M |
| October 23, 2026 | -1.033M |
| October 22, 2026 | -1.155M |
| October 21, 2026 | -1.155M |
| October 20, 2026 | -1.217M |
| October 19, 2026 | -1.110M |
| October 16, 2026 | -1.112M |
| October 15, 2026 | -1.112M |
| October 14, 2026 | -1.236M |
| October 13, 2026 | -1.341M |
| October 12, 2026 | -1.158M |
| October 09, 2026 | -1.154M |
| October 08, 2026 | -1.151M |
| October 07, 2026 | -1.217M |
| October 06, 2026 | -1.158M |
| October 05, 2026 | -1.158M |
| Date | Value |
|---|---|
| October 02, 2026 | -1.435M |
| October 01, 2026 | -1.040M |
| September 30, 2026 | -1.095M |
| September 29, 2026 | -1.283M |
| September 28, 2026 | -1.261M |
| September 25, 2026 | -1.099M |
| September 24, 2026 | -1.184M |
| September 23, 2026 | -1.187M |
| September 22, 2026 | -1.040M |
| September 21, 2026 | -1.452M |
| September 18, 2026 | -1.217M |
| September 17, 2026 | -1.158M |
| September 16, 2026 | -1.305M |
| September 15, 2026 | -1.924M |
| September 14, 2026 | -2.381M |
| September 11, 2026 | -2.371M |
| September 10, 2026 | -2.317M |
| September 09, 2026 | -2.137M |
| September 08, 2026 | -2.219M |
| September 04, 2026 | -2.164M |
| September 03, 2026 | -2.164M |
| September 02, 2026 | -2.219M |
| September 01, 2026 | -2.219M |
| August 31, 2026 | -2.076M |
| August 28, 2026 | -2.122M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.764B |
| Alnylam Pharmaceuticals, Inc. | 20.29B |
| Anika Therapeutics, Inc. | 176.07M |
| Savara, Inc. | 849.45M |
| Vericel Corp. | 2.710B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.94M |
| Total Expenses (Quarterly) | 0.94M |
| EPS Diluted (Quarterly) | -0.1594 |
| Earnings Yield | 180.1% |
| Normalized Earnings Yield | -159.52 |